These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12386920

  • 41. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
    Rocchi P, Beraldi E, Ettinger S, Fazli L, Vessella RL, Nelson C, Gleave M.
    Cancer Res; 2005 Dec 01; 65(23):11083-93. PubMed ID: 16322258
    [Abstract] [Full Text] [Related]

  • 42. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
    Chen Z, Koeneman KS, Corey DR.
    Cancer Res; 2003 Sep 15; 63(18):5917-25. PubMed ID: 14522918
    [Abstract] [Full Text] [Related]

  • 43. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
    Litvinov IV, Antony L, Dalrymple SL, Becker R, Cheng L, Isaacs JT.
    Prostate; 2006 Sep 01; 66(12):1329-38. PubMed ID: 16835890
    [Abstract] [Full Text] [Related]

  • 44. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA.
    Prostate; 2008 Jul 01; 68(10):1133-42. PubMed ID: 18454446
    [Abstract] [Full Text] [Related]

  • 45. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 46. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
    Saleem M, Kweon MH, Yun JM, Adhami VM, Khan N, Syed DN, Mukhtar H.
    Cancer Res; 2005 Dec 01; 65(23):11203-13. PubMed ID: 16322271
    [Abstract] [Full Text] [Related]

  • 47. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells.
    Yu BW, Nguyen D, Anderson S, Allegra CA.
    Anticancer Res; 1997 Dec 01; 17(6D):4407-13. PubMed ID: 9494542
    [Abstract] [Full Text] [Related]

  • 48. Beta-human chorionic gonadotropin in semen: a marker for early detection of prostate cancer?
    Daja MM, Aghmesheh M, Ow KT, Rohde PR, Barrow KD, Russell PJ.
    Mol Urol; 2000 Dec 01; 4(4):421-7. PubMed ID: 11156711
    [Abstract] [Full Text] [Related]

  • 49. [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice].
    Zhang Y, Ma Y, Lu HP, Zhou XF, Xie Y, Gao JH, Liang CS.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 29; 88(29):2073-6. PubMed ID: 19080439
    [Abstract] [Full Text] [Related]

  • 50. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
    Wang LG, Liu XM, Fang Y, Dai W, Chiao FB, Puccio GM, Feng J, Liu D, Chiao JW.
    Int J Oncol; 2008 Aug 29; 33(2):375-80. PubMed ID: 18636159
    [Abstract] [Full Text] [Related]

  • 51. Regulation of growth hormone receptors in human prostate cancer cell lines.
    Bidosee M, Karry R, Weiss-Messer E, Barkey RJ.
    Mol Cell Endocrinol; 2009 Oct 15; 309(1-2):82-92. PubMed ID: 19540305
    [Abstract] [Full Text] [Related]

  • 52. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL, Lin JK.
    Prostate; 2008 Jan 01; 68(1):61-71. PubMed ID: 18008333
    [Abstract] [Full Text] [Related]

  • 53. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.
    You Z, Shi XB, DuRaine G, Haudenschild D, Tepper CG, Lo SH, Gandour-Edwards R, de Vere White RW, Reddi AH.
    Cancer Res; 2006 Jan 01; 66(1):175-83. PubMed ID: 16397230
    [Abstract] [Full Text] [Related]

  • 54. Role of c-myc protein in hormone refractory prostate carcinoma: cellular response to paclitaxel.
    Cassinelli G, Supino R, Zuco V, Lanzi C, Scovassi AI, Semple SC, Zunino F.
    Biochem Pharmacol; 2004 Sep 01; 68(5):923-31. PubMed ID: 15294455
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C, Connell Y, Neckers L.
    Mol Pharmacol; 1995 Oct 01; 48(4):738-46. PubMed ID: 7476902
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Abrupt reduction of c-myc expression by antisense RNA inducing terminal differentiation and apoptosis of a human esophageal cancer cell line.
    Zhao X, Wang X, Zhou C, Peng R, Yan S, Wu M.
    Sci China B; 1995 May 01; 38(5):580-9. PubMed ID: 7626199
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells.
    Taj MM, Tawil RJ, Engstrom LD, Zeng Z, Hwang C, Sanda MG, Wechsler DS.
    Prostate; 2001 May 15; 47(3):194-204. PubMed ID: 11351349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.